FDA Releases Draft Guidance on Inhalation Drug Products in Semipermeable Containers

Summary

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on inhalation drug products packaged in semipermeable container closure systems, aiming to address concerns about chemical contaminants leaching into these products. The guidance covers chemistry, manufacturing, and controls considerations.